Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
44.70
+0.68 (1.54%)
At close: Nov 10, 2026, 4:00 PM EST
44.90
+0.20 (0.45%)
After-hours: Nov 10, 2026, 7:59 PM EST
Boston Scientific Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, Boston Scientific stock has a consensus rating of "Buy" and an average price target of $49.6. The average 1-year stock price forecast is 10.96% higher than the current stock price, while the lowest is $41 (-8.28%) and the highest is $60 (+34.23%).
Price Target: $49.6 (+10.96%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Boston Scientific stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 20 | 18 | 18 | 17 | 14 | 14 |
| Buy | 7 | 8 | 8 | 8 | 6 | 5 |
| Hold | 4 | 5 | 5 | 6 | 11 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 31 | 31 | 31 | 31 | 31 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $48 | Buy | Maintains | $48 | +7.38% | Nov 4, 2026 |
| Argus Research | Argus Research | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 3, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 3, 2026 |
| Citi | Citi | Hold Reiterates $48 → $44 | Hold | Reiterates | $48 → $44 | -1.57% | Nov 2, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $54 | Buy | Reiterates | $54 | +20.81% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
20.97B
from 20.07B
Increased by 4.46%
Revenue Next Year
20.88B
from 20.97B
Decreased by -0.43%
EPS This Year
3.17
from 3.06
Increased by 3.66%
EPS Next Year
3.13
from 3.17
Decreased by -1.30%
EPS and Forward PE are based on non-GAAP adjusted numbers.